VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 50 filers reported holding VIRACTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,560 | -26.2% | 14,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $19,740 | -11.3% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $22,260 | +8.9% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $20,440 | -65.9% | 14,000 | 0.0% | 0.00% | -71.4% |
| Q3 2022 | $60,000 | +11.1% | 14,000 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $54,000 | -19.4% | 14,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $67,000 | +31.4% | 14,000 | 0.0% | 0.01% | +50.0% |
| Q4 2021 | $51,000 | -54.5% | 14,000 | 0.0% | 0.00% | -63.6% |
| Q3 2021 | $112,000 | -29.6% | 14,000 | 0.0% | 0.01% | -8.3% |
| Q2 2021 | $159,000 | +22.3% | 14,000 | 0.0% | 0.01% | -7.7% |
| Q1 2021 | $130,000 | – | 14,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $1,120,000 | 0.80% |
| Samsara BioCapital, LLC | 689,709 | $2,676,000 | 0.71% |
| BVF INC/IL | 3,614,662 | $14,025,000 | 0.68% |
| HAMILTON LANE ADVISORS LLC | 71,491 | $277,000 | 0.11% |
| MAI Capital Management | 647,950 | $2,514,000 | 0.05% |
| Laurion Capital Management LP | 698,000 | $2,708,000 | 0.04% |
| Jasper Ridge Partners, L.P. | 92,939 | $361,000 | 0.02% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,500 | $80,000 | 0.02% |
| Ergoteles LLC | 155,562 | $604,000 | 0.02% |
| Clear Harbor Asset Management, LLC | 25,000 | $97,000 | 0.01% |